trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

MRNA COVID-19 vaccines are delivered intramuscularly to optimize immune response generation

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Standard mRNA COVID-19 vaccines are administered intramuscularly to safely and effectively generate systemic immune responses against SARS-CoV-2.

The analysis

The retrieved papers consistently state that current approved COVID-19 vaccines, including mRNA platforms, are administered via the intramuscular route to induce robust systemic immunity.

Evidence for · 4
An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection
Recorded source metadata

P. van der Ley, A. Zariri, E. van Riet, D. Oosterhoff, C. Kruiswijk. An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection. 2021. https://doi.org/10.3389/fimmu.2021.781280

Notes that currently all registered COVID-19 vaccines are intramuscularly administered, targeting the induction of systemic immunity.

See more details
More for · 3
Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge
Recorded source metadata

T. Wong, Katherine S. Lee, B. Russ, A. Horspool, Jason Kang, Michael T. Winters, M. Allison Wolf, Nathaniel A. Rader, Olivia A. Miller, Morgane Shiflett, Jerilyn R Izac, D. Varisco, Emel Sen-Kilic, Casey Cunningham, Melissa Cooper, H. Cyphert, M. Barbier, I. Martinez, J. Bevere, R. Ernst, F. Damron. Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge. 2022. https://doi.org/10.1038/s41541-022-00451-7

Indicates that all current WHO-approved COVID-19 vaccines are administered through the muscular route.

Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both
Recorded source metadata

S. Beitari, Gerard Agbayani, Melissa Hewitt, D. Duque, J. Bavananthasivam, J. Sandhu, Bassel Akache, I. Hadžisejdić, A. Tran. Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both. 2023. https://doi.org/10.1038/s41598-023-48397-7

States that most vaccine platforms used at the forefront are administered by intramuscular injection.

Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution.
Recorded source metadata

Xu X, Cui L, Zhang Y, Gu J. Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution.. 2026. https://doi.org/10.1016/j.apsb.2025.11.023

Discusses the clinical success and biological fate of mRNA-LNP-based vaccines which are administered parenterally.

The paper trail · every fact has a biography
first checked02 Aug 2026
judged → SUPPORTED · 8802 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.
trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt